.
In recent years, there have been a number of reports on useful trials carried out to control the infections caused by VRE (Garner, 1996; Slaughter et al., 1996; Montecalvo et al., 1999; Nourse et al., 2000; Hanna et al., 2001; Montecalvo et al., 2001; Shaikh et al., 2002; Calfee et al., 2003; Warren et al., 2004; Mascini and Bonten, 2005; Zoutman and Ford, 2005) and MRSA (Voss et al., 1994 ; Coolson, 1995; Cox et al., 1995; Working Party Report, 1998; Kotilainen et al., 2001; Hori, 2002; Bissett, 2005; Schelenz et al., 2005) .
However, further trials would be necessary to find more reliable methods to control the VRE and MRSA infections adequately. In this context, the use of natural products as anti-VRE and anti-MRSA agents would be a promising area of investigation leading towards the eventual prevention and treatment of VRE and MRSA infections. Furthermore, it would be very important to investigate the synergistic activities of the active natural products and commercially available antibiotics, with the hope of enhancing their activity.
Recently the and-MRSA activity of natural products such as flavonoids, for example, sophoraflavanone G (Sato et al., 1995) , xanthones such as rubraxanthone (linuma et al., 1996) , and oligostilbenes such as hemsleyanol D and gnetin E (Nitta et al., 2002) have been reported. Resveratrol, one of the stilbene derivatives, is well known as one of the polyphenol phytoalexins found in grapes and wine, and is a strong chemopreventive agent with promising safety records with regard to human consumption and unique forms of cell death induction in a variety of tumor cells (Mohan et al., 2006) .
There have been some reports about the antibacterial activity of stilbene (Atef et al., 1979; Inamori et al., 1991; Wyrzykiewicz et al.,1994; Wyrzykiewicz et al., 2000; Venkateswarlu et al., 2002) , but none about the antibacterial activity of stilbene oligomers against bacteria including VRE and MRSA.
In the present experiment we tested the anti-VRE and anti-MRSA activities of 37 stilbene oligomers isolated from Gnetaceous plants (Iliya et al., 2002a (Iliya et al., , 2002b . In addition, their synergistic activities with the commercially available antibiotics such as ampicillin (ABPC), gentamicin (GM), minocycline (MINO), fosfomycin (FOM) and vancomycin hydrochloride (VCM) were also investigated.
MATERIALS AND METHODS

Stilbene oligomers
Among the stilbene oligomers isolated from Gnetum species (G. africanum, G. gnemon and G. gnemonoides), 37 compounds shown in Table 1 were used in the present experiment.
Antibiotics
Ampicillin (ABPC), gentamicin (GM), minocycline (MINO), fosfomycin (FOM) and vancomycin hydrochloride (VCM) were used for the synergistic studies.
Tested bacteria VRE: Five strains of VRE (Enterococcus faecalis ATCC 51299, E. faecalis ATCC 51575, E faecium ATCC 51559, E faecium KIHC-237 and E. gallinarum KIHC-241) were used in this experiment. The three ATCC strains were purchased from the American Type Culture Collection (ATCC). Two strains of E faecium KIHC-237 and E gallinarum KIHC-241 were supplied by the Kobe Institute of Public Health. The genotypes of E faecalis ATCC 51299, E. faecium KIHC-237 and E gallinarum KIHC-241 are van B(+), van A (+) and van C1 (+), respectively. The genotypes of the other two VRE, E. faecalis ATCC 51575 and E. faecium ATCC 51559 were unknown. VSE:
Three strains of vancomycin-sensitive (ATCC 43888), Klebsiella pneumoniae NBRC 13277 and Pseudomonas aeruginosa NBRC 13275, no activity was observed (data not shown). Synergism between gnemonol B or gnetin E and the commercially available antibiotics such as ABPC, GM, MINO, FOM and VCM was also investigated. In the present study gnemonol B showed partial synergism with ABPC, GM, MINO, FOM and VCM against VRE. Partial synergism was also found in the combination of gnemonol B with GM against MRSA. Furthermore, partial synergism of gnetin E with GM and VCM against VRE, and that of gnetin E with GM, MINO, FOM and VCM against VRE were also found. These activities of partial synergism were reconfirmed by our results obtained from the test described by Williamson (2001) (data not shown) .
The use of phytoalexin (the antibacterial compound) isolated from the natural products would be considerably valuable for the controlling of infectious bacteria such as VRE and MRSA, etc. The main reason was as follows. No reports have been found about bacteria resistant to natural products including the tested stilbene oligomers (gnemonol B and gnetin E). The use of the antibiotics would be decreased because of the partial synergism between gnemonol B or gnetin E and the commercially available antibiotics, and the detection ratio of the resistant bacteria would become lower.
From the above mentioned results, these findings suggested that the use of gnemonol B or gnetin E alone or in combination with some antibiotics could be useful in controlling and treating VRE and MRSA infections. Further investigation will be performed using in vivo trials in the near future. Good results would be expected in such in vivo investigations of gnemonol B and gnetin E.
Recently we reported the anti-VRE and anti-MRSA activities of a -mangostin isolated from the stem bark of Garcinia mangostana L. (Sakagami et al., 2005) . In this report, we also found the strong anti-VRE and anti-MRSA active agents in natural products. These results might be valuable for the controlling of nosocomial infectious bacteria such as VRE and MRSA.
